A broadly neutralizing human monoclonal antibody against the hemagglutinin of avian influenza virus H7N9
Abstract. Background:. The new emerging avian influenza A H7N9 virus, causing severe human infection with a mortality rate of around 41%. This study aims to provide a novel treatment option for the prevention and control of H7N9. Methods:. H7 hemagglutinin (HA)-specific B cells were isolated from pe...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2022-04-01
|
Series: | Chinese Medical Journal |
Online Access: | http://journals.lww.com/10.1097/CM9.0000000000002001 |